title: [Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement : a case report].
abstract: A 63-year-old man who had undergone radical cystectomy and ileal conduit formation for invasive bladder cancer 3 years before presented with continuous positive urinary cytology in the ileal conduit. His diagnosis was carcinoma in situ (CIS) of the left upper urinary tract. He was treated with Bacillus Calmette-Guérin (BCG) perfusion therapy using a single-J ureteric stent. BCG (80 mg) in 100 ml saline was instilled in a one-hour period weekly for 6 weeks. Usage of another catheter was effective for continuing the therapy. Urinary cytology in the left upper urinary tract and the ileal conduit became negative after the therapy. There was no evidence of recurrence or metastasis of urothelial carcinoma 6 months after the therapy.
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Takuji
authors.initials: T
authors.lastname: Hayashi
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Yohei
authors.initials: Y
authors.lastname: Yamanaka
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Takanori
authors.initials: T
authors.lastname: Kinjo
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Kinzo
authors.initials: K
authors.lastname: Katayama
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Akihito
authors.initials: A
authors.lastname: Kamoto
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Naoki
authors.initials: N
authors.lastname: Mori
authors.affiliation: The Department of Urology, Sumitomo Hospital.
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Yoshioka
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents; D001749:Urinary Bladder Neoplasms / Q000628:therapy; D014547:Urinary Diversion; D014571:Urologic Neoplasms / Q000628:therapy*
chemical_list: D001500:BCG Vaccine